<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20131225015932N17</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-29</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effects of transcranial direct current stimulation (tDCS) plus exercise with exercise alone on pain, function and balance in individuals with patellofemoral pain</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effects of transcranial direct current stimulation (tDCS) plus exercise with exercise alone on pain, function and balance in individuals with patellofemoral pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-12-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65921</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: In this study, according to previous related studies, the necessary sample size of 20 subjects (10 subjects in each group) will be considered, and considering 20% dropout and a 1:1 ratio (intervention: control), at least 12 subjects will be considered for each group. Allocation of participants to groups will be based on the block randomization method. One month after interventions both groups will be evaluated for follow-up, Randomization description: Allocation of patients into 2 intervention and control groups is done by the block randomization method. The allocation sequence is generated using the free web system at http://www.randomization.com. Opaque and sealed envelopes will be used to hide the allocation of patients to groups, Blinding description: The physiotherapist who will measure the outcome  measures and the physiotherapist who will analyze the outcome measures  will be blinded to the patient’s allocation group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patellofemoral pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: real tDCS plus knee, hip, and trunk strengthening exercises:  In this group, the participants will receive 20 minutes of real tDCS for one month and 3 sessions per week, with the method of placing the anode on the CZ and the cathode on the middle of the forehead with a current of 2 mA and then they will do stretching exercises for quadriceps, hamstrings, iliotibial band, and calf muscles (3 repetitions, 30-second hold) and knee and hip and trunk strengthening exercises including quadriceps setting, terminal knee extension, straight leg raise, and hip abductor and external rotator, and Transversus abdominis and multifidus muscle training: Quadruped and prone with 10-second isometric contraction in the first and second week and 15 seconds in 3rd and 4th week, Sitting on the Swiss ball: with 20-second isometric contraction in the first and second week and 25 seconds in 3rd and 4th week, ventral bridge and lateral bridge with 30 seconds hold in the first and second week and 35 seconds hold in 3rd and 4th week. Each session almost will take time 60 minutes. Intervention 2: Control group: sham tDCS plus knee, hip, and trunk strengthening exercises:  In this group, the participants will receive 20 minutes of sham tDCS for one month and 3 sessions per week, with the method of placing the anode on the CZ and the cathode on the middle of the forehead (but the current is only on for 10 seconds and then it is cut off). And then they will do stretching exercises for quadriceps, hamstring, iliotibial band, and calf muscles (3 repetitions, 30-second hold) and knee and hip and trunk strengthening exercises including quadriceps setting, terminal knee extension, straight leg raise, and hip abductor and external rotator, and Transversus abdominis and multifidus muscle training: Quadruped and prone with 10-second isometric contraction in the first and second week and 15 seconds in 3rd and 4th week, Sitting on the Swiss ball: with 20-second isometric contraction in the first and second week and 25 seconds in 3rd and 4th week, ventral bridge and lateral bridge with 30 seconds hold in the first and second week and 35 seconds hold in 3rd and 4th week. Each session almost will take time 60 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is I haven't decided yet</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Mohtashamzade</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>NO.32, Abiverdi 1 Avenue, Chamran Blvd, Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3366971947</zip>
        <telephone>+98 71 3336 1081</telephone>
        <email>z.mohtashamzade@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Alireza Motealleh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>NO.32, Abiverdi 1 Avenue, Chamran Blvd, Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3366971947</zip>
        <telephone>+98 71 3336 1081</telephone>
        <email>motealleh@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Women and men aged 18-40 years/old with unilateral patellofemoral pain
Anterior knee pain  provoked by at least 2 of the following activities: prolonged sitting, ascending or descending stairs, squatting, kneeling, jumping, running
Pain on palpation of the medial and lateral patellar facets, and positive Clarke's sign
Insidious onset of symptoms without a history of  trauma and injury
Average pain level of at least 3 out of 10 on VAS during the previous week in activities of daily living (ADL)
Kujula scores 50-80
The presence of pain for at least 3 months</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Other knee joint pathologies such as meniscus and ligament injuries, osteoarthritis and tendon impairments; Self-reported history of patellar subluxation or dislocations; plica syndrome and Osgood-Schlatter disease; trauma in hip; knee or ankle joint
Previous knee surgery
Radicular pain from other joints including lumbar spine, hip and sacroiliac joints
Metabolic disorders such as Diabetes; neurological, and rheumatology diseases  such as Stroke; MS; RA and balance disorders and peripheral Neuropathies
Professional athletes  who participates in a specific sport at least 2 h /day and 3 times a week regularly
Pregnancy
Heart diseases
Consumption of alcohol and drugs that affect the central nervous system and balance such as Dextromethorphan and D_cycloserine
Diseases that interfere with tDCS, such as history of epilepsy, history of brain surgery, brain tumor, brain implants
Cognitive disorders due to the consumption of alcohol and drugs in the last six months
Uncorrected vision and hearing impairment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M22.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Patellofemoral disorders</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: real tDCS plus knee, hip, and trunk strengthening exercises:  In this group, the participants will receive 20 minutes of real tDCS for one month and 3 sessions per week, with the method of placing the anode on the CZ and the cathode on the middle of the forehead with a current of 2 mA and then they will do stretching exercises for quadriceps, hamstrings, iliotibial band, and calf muscles (3 repetitions, 30-second hold) and knee and hip and trunk strengthening exercises including quadriceps setting, terminal knee extension, straight leg raise, and hip abductor and external rotator, and Transversus abdominis and multifidus muscle training: Quadruped and prone with 10-second isometric contraction in the first and second week and 15 seconds in 3rd and 4th week, Sitting on the Swiss ball: with 20-second isometric contraction in the first and second week and 25 seconds in 3rd and 4th week, ventral bridge and lateral bridge with 30 seconds hold in the first and second week and 35 seconds hold in 3rd and 4th week. Each session almost will take time 60 minutes.</i_keyword>
      <i_keyword>Control group: sham tDCS plus knee, hip, and trunk strengthening exercises:  In this group, the participants will receive 20 minutes of sham tDCS for one month and 3 sessions per week, with the method of placing the anode on the CZ and the cathode on the middle of the forehead (but the current is only on for 10 seconds and then it is cut off). And then they will do stretching exercises for quadriceps, hamstring, iliotibial band, and calf muscles (3 repetitions, 30-second hold) and knee and hip and trunk strengthening exercises including quadriceps setting, terminal knee extension, straight leg raise, and hip abductor and external rotator, and Transversus abdominis and multifidus muscle training: Quadruped and prone with 10-second isometric contraction in the first and second week and 15 seconds in 3rd and 4th week, Sitting on the Swiss ball: with 20-second isometric contraction in the first and second week and 25 seconds in 3rd and 4th week, ventral bridge and lateral bridge with 30 seconds hold in the first and second week and 35 seconds hold in 3rd and 4th week. Each session almost will take time 60 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: First,12th session and 1 month after interventions. Method of measurement: Visual Analogue Scale (VAS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Function. Timepoint: First, 12th session, and 1 month after interventions. Method of measurement: Kujala questioner.</sec_outcome>
      <sec_outcome>Function. Timepoint: First, 12th session, and 1 month after interventions. Method of measurement: Step down test.</sec_outcome>
      <sec_outcome>Static balance. Timepoint: First,12th session and 1 month after interventions. Method of measurement: Single leg stance balance test.</sec_outcome>
      <sec_outcome>Dynamic balance. Timepoint: First,12th session and 1 month after interventions. Method of measurement: Modified star excursion balance test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-09-16</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Rehabilitation school of Shiraz University of Medical Sciences, Abivardi Ave., Chamran Boulevard shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
